137 related articles for article (PubMed ID: 11168756)
1. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.
Bayer-Garner IB; Smoller BR
J Cutan Pathol; 2001 Feb; 28(2):83-9. PubMed ID: 11168756
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma.
Bayer-Garner IB; Sanderson RD; Smoller BR
J Cutan Pathol; 1999 Sep; 26(8):386-90. PubMed ID: 10551410
[TBL] [Abstract][Full Text] [Related]
3. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin.
Griffin JR; Wriston CC; Peters MS; Lehman JS
Am J Clin Pathol; 2013 Apr; 139(4):442-7. PubMed ID: 23525614
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.
Leppä S; Vleminckx K; Van Roy F; Jalkanen M
J Cell Sci; 1996 Jun; 109 ( Pt 6)():1393-403. PubMed ID: 8799827
[TBL] [Abstract][Full Text] [Related]
6. Reduction of syndecan-1 expression is associated with dysplastic oral epithelium.
Soukka T; Pohjola J; Inki P; Happonen RP
J Oral Pathol Med; 2000 Aug; 29(7):308-13. PubMed ID: 10947246
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation.
Inki P; Stenbäck F; Talve L; Jalkanen M
Am J Pathol; 1991 Dec; 139(6):1333-40. PubMed ID: 1750507
[TBL] [Abstract][Full Text] [Related]
8. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
9. The role of syndecan-1 in malignancies.
Inki P; Jalkanen M
Ann Med; 1996 Feb; 28(1):63-7. PubMed ID: 8932508
[TBL] [Abstract][Full Text] [Related]
10. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence.
Day RM; Hao X; Ilyas M; Daszak P; Talbot IC; Forbes A
Virchows Arch; 1999 Feb; 434(2):121-5. PubMed ID: 10071246
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma.
Bayer-Garner IB; Dilday B; Sanderson RD; Smoller BR
Am J Dermatopathol; 2000 Apr; 22(2):119-22. PubMed ID: 10770430
[TBL] [Abstract][Full Text] [Related]
12. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
13. Acantholysis and spongiosis are associated with loss of syndecan-1 expression.
Bayer-Garner I; Dilday B; Sanderson R; Smoller B
J Cutan Pathol; 2001 Mar; 28(3):135-9. PubMed ID: 11168765
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer.
Huang MF; Zhu YQ; Chen ZF; Xiao J; Huang X; Xiong YY; Yang GF
World J Gastroenterol; 2005 May; 11(19):2975-80. PubMed ID: 15902740
[TBL] [Abstract][Full Text] [Related]
15. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.
Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390
[TBL] [Abstract][Full Text] [Related]
17. Oral variant of acantholytic squamous cell carcinoma-Histochemical and immunohistochemical features.
Allon I; Abba M; Kaplan I; Livoff A; Zaguri A; Nahlieli O; Vered M
Acta Histochem; 2019 Nov; 121(8):151443. PubMed ID: 31706621
[TBL] [Abstract][Full Text] [Related]
18. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells.
Burbach BJ; Ji Y; Rapraeger AC
Exp Cell Res; 2004 Oct; 300(1):234-47. PubMed ID: 15383330
[TBL] [Abstract][Full Text] [Related]
20. [The expression of cell adhesion molecule Syndecan-1 and E-candherin in laryngeal cancer].
Li Y; Yang C
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 17(12):736-8. PubMed ID: 15017723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
